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Abstract
Radiation induced angiosarcomas (RIA) can affect breast cancer patients who had radiotherapy
following conservative breast surgery. They are very rare tumors and often their diagnosis is
delayed due to their benign appearance and difficulty in differentiation from radiation induced skin
changes. Therefore it is very important that clinicians are aware of their existence. We report here
a case of RIA followed by discussion and review of literature.
Background
Angiosarcomas are rare tumors of endovascular origin.
Primary angiosarcomas account for only 0.04% of breast
tumors. It affects a younger age group of 20–40 yrs. Sec-
ondary angiosarcoma can be induced by radiotherapy.
Cases of radiation induced angiosarcoma (RIA) have been
reported in women who had radiotherapy for breast can-
cer. RIA occurs in an older age group, with a mean age of
68 years [1]. It is difficult to diagnose due to its rarity,
benign appearance and difficulty in differentiation from
radiation induced changes in the skin [2].
We report a case of Angiosarcoma in a 78 years old
woman. She had radiotherapy for breast cancer following
conservative surgery and axillary node clearance.
Case report
Clinical history
In April 1996 this 78-year-old woman was diagnosed with
a poorly differentiated lobular carcinoma in the upper
outer part of the left breast. Clinically it measured 15 mm.
She was treated with conservative breast surgery and level
III axillary node clearance. Tumor margins were clear and
all lymph nodes were negative. Tamoxifen was com-
menced at 20 mg OD.
A course of postoperative radiotherapy was arranged due
to breast conservation surgery. She received 46 Gy in 23
fractions over 35 days using paired glancing megavoltage
fields. This treatment was completed in July 1996 and was
followed by a boost to the site of excision of a further 12
Gy in 4 fractions over 7 days using 9MEV electrons. Chem-
otherapy was discussed but the patient did not want to
pursue this option.
She remained in regular follow up with no evidence of
local or regional recurrence. In June 2005 during a routine
follow up appointment she reported a 2 cm area of purple
skin lesion at the lower inner quadrant of the left breast
(figure 1), with a history of it being there for about 3
months. It was associated with peau d'orange and soft tis-
sue thickening extending from the lower inner quadrant
across the midline. Mammography was not performed, as
she was too tender. Ultrasound showed no evidence of a
lesion deep to the abnormality. Freehand core biopsies
were taken of the area. Pathology demonstrated the pres-
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ence of malignancy in keeping with high-grade angiosar-
coma.
Staging investigations including CT chest and abdomen,
CXR and bone scan none showed any evidence of metas-
tasis. She had wide surgical excision and reconstruction
with a Vertical Rectus Abdominus Myocutaneous flap
(VRAM flap). She has completed her first year follow up
without any recurrence.
Pathologic findings
Histological examination following routine processing
and staining with haemotoxylin and eosin shows malig-
nant tumor (figure 2). Although this tumor is predomi-
nantly solid, comprising highly pleomorphic cells (figure
3) and areas with spindle cell morphology (figure 4) neo-
plastic vascular channels are also identified (figure 5).
Immunohistochemical staining for CD31, CD34 and fac-
tor viii confirm endothelial differentiation both within
the solid tumor component and the recognizable vascular
channels. The possible differential diagnoses of carci-
noma and malignant melanoma are excluded by the neg-
ativity of other stains (MNF and S100 respectively). The
histological features are those of high grade angiosar-
coma.
Histology from the original breast excision biopsy (figure
6) shows a lobular carcinoma, with strong oestrogen
receptor positivity. This shows no similarity to the newly
arising angiosarcoma.
Discussion and review of literature
Radiation induced sarcomas were first reported in litera-
ture in 1929[3] and the first case of sarcoma after radio-
therapy for breast cancer was reported by Warren &
Sommer in 1936[4]. Cahan et al [5] described the diag-
nostic criteria for Radiation induced sarcomas which
include a previous history of radiotherapy with a latency
period of several years (5 or more), development of sar-
coma within a previous irradiated field and a histologic
confirmation. This criterion was modified by Arlen et al
[6] to include tissues adjacent to the radiated field and a
shorter latency period of 3–4 years. Radiation induced
angiosarcomas are characterized by their aggressive nature
and most are high grade tumors [7,8]. They can develop
after many years in women who have previously had radi-
otherapy for breast cancer.
At high power magnification (×40) there are highly pleomor- phic cells with prominent nucleoli Figure 3
At high power magnification (×40) there are highly pleomor-
phic cells with prominent nucleoli. Many mitotic figures are 
seen (arrows). Some individual apoptotic cells are also 
present.
Radiation induced Angiosarcoma (left breast) following con- servative surgery for breast cancer in a 78 years old lady Figure 1
Radiation induced Angiosarcoma (left breast) following con-
servative surgery for breast cancer in a 78 years old lady.
Histological sections from the biopsy at low power (4 × mag- nifications) show infiltration by a tumor with both solid areas  and neoplastic vascular channels Figure 2
Histological sections from the biopsy at low power (4 × mag-
nifications) show infiltration by a tumor with both solid areas 
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The etiology of radiation induced angiosarcomas in the
breast remains controversial. Some investigators believe
that many of the reported cases are actually metaplastic
variants of the original Cancer [9,10]. Radiation induced
metaplastic transformation is thought to be related to irre-
versible DNA damage [11]. Immunohistochemical stains
of tumor tissue for factor VIII – related antigen & Ulex lec-
tin stains are required to confirm the diagnosis of angiosa-
rcoma and to differentiate it from the metaplastic
recurrent breast cancer [7,8]. In our case we have per-
formed these tests to confirm the diagnosis.
Most cases of RIA occur in association with a total radia-
tion dose in the range of 40–50 Gy [8,12]. It is difficult to
analyze the relationship between the total radiation dose,
individual fraction dose and the incidence of RIA, due to
the rarity of cases in the literature and the difficulty in
retrieving information many years after the primary treat-
ment. A minimum total dose of 10 Gy in conventional
doses per fraction appears necessary to result in RIA
[13,14].
The incidence of RIA following radiotherapy to the breast
varies from 0.05 to 0.2 % [15-17] with an average latency
period reported as 12.5 years [18,19].
The presentation of RIA is often a cutaneous or subcutane-
ous lesion, painless, flat or nodular, bluish or purplish
similar to benign angiomas, small hematomas or atypical
telangiectasis [20,21]. Its diagnosis is often delayed by 8–
12 months [8,11] due to a lack of specific symptoms and
low suspicion following a long latency period after diag-
nosis of original tumor. Additional reasons cited for
delayed diagnosis include difficulty in detecting the
tumor in previously irradiated tissue and inadequate
biopsies [2].
A high index of suspicion, careful patient evaluation and
adequate biopsy tissue for pathologic diagnosis is manda-
tory. Mammography is typically negative in these cases [2]
and diagnosis can be confirmed only by histopathological
study of the biopsy. Cytology is generally misleading and
not very informative [2].
There is general consensus in literature that the only logi-
cal treatment of RIA regardless of histologic type is wide
surgical resection i.e. Mastectomy usually with a latis-
At medium power (×20 magnification), histology from the  original breast excision biopsy shows infiltrating strands of  tumor cells with some pleomorphism Figure 6
At medium power (×20 magnification), histology from the 
original breast excision biopsy shows infiltrating strands of 
tumor cells with some pleomorphism. The tumor also forms 
circumscribed nodules. This shows a high power view (×40 magnification) of an area  with spindle cell morphology Figure 4
This shows a high power view (×40 magnification) of an area 
with spindle cell morphology.
This high power view (×40 magnification) shows neoplastic  vascular channels Figure 5
This high power view (×40 magnification) shows neoplastic 
vascular channels. These irregular channels interconnect and 
are lined by a single layer of highly atypical endothelial cells 
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simus dorsi flap reconstruction. Conservative treatment
even with negative margins exposes the patient to early
recurrences and metastatic spread [2,17-20,22].
Adjuvant Chemotherapy in RIA has so far produced disap-
pointing results [22].
Radiation therapy has been avoided in these cases second-
ary to concerns about the toxicity of repeated treatment.
However recently some encouraging results have been
achieved with the use of hyperfractionated radiotherapy
[23].
Median survival in RIA is reported from1.5 to 2.5 years
[17]. Recurrence rates approach 70 % and 2-year disease
free survival ranges from 0–35 % in various series [15,16].
Conclusion
This lesion is still rare, but with the increase in conserva-
tive breast surgery and radiotherapy, the incidence of RIA
is likely to increase. Due to benign looking nature of the
tumor in initial stages only a high index of suspicion and
generous tissue biopsy can lead to early diagnosis. From
review of the literature it is evident that early diagnosis
and aggressive surgical approach can lead to a better prog-
nosis. Chemotherapy has yet achieved no role in the treat-
ment of these tumors but recently some encouraging
results are seen with the use of Hyperfractionated radio-
therapy and further work needs to be done in this regards.
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